PROPOFOL B.Braun

PROPOFOL B.Braun
PROPOFOL B.Braun

PROPOFOL B.Braun

PROPOFOL-LIPURO ® 10 mg/ml and 20 mg/ml

Propofol-®Lipuro is a highly innovative product from B. Braun’s unique Lipuro®-Technology, which uses MCT/LCT lipid emulsion as the drug delivery base with excellent solubility and stability.

 

The improved formulation entail

  •  Significant reduction of injection pain
  •  Reduction of lipid and fluid load
  •  Optimized lipid metabolism
  •  Maintenance of immune response
  •  No negative effects on pulmonary function

 

 

 

 

 

The favorable properties of propofol in clinical use are given full scope, e.g.

• Rapid onset and short duration of effects
• Excellent control of anesthesia
• Outstanding safety
• Good tolerability

 

Presentaion

10 mg/ml ,50 ml Vial, and 20 ml Ampule
20mg/ml 50 ml Vial


Therapeutic indications for PROPOFOL- LIPURO® 10 mg/ml

Propofol-Lipuro 10mg/ml is a short-acting intravenous general anesthetic indicated for:

• Induction and maintenance of general anesthesia in adults and children over 1 month of age
• sedation of ventilated patients in the intensive care unit for adult over 16 years of age

  • Sedation for diagnostic and surgical procedures, alone or in combination with local or regional anesthesia for adults and children over 1 month of age

 

Therapeutic indications for PROPOFOL- LIPURO® 20 mg/ml

Propofol-Lipuro 20 mg/ml is a short-acting intravenous general anesthetic indicated for:

• Induction and maintenance of general anesthesia in adults and children over 3 years of age
• sedation of ventilated patients in the intensive care unit for adult over 16 years of age

  • Sedation for diagnostic and surgical procedures, alone or in combination with local or regional anesthesia for adults and children over 3 years of age